1. Macedo TC, Montagna E, Trevisan CM, Zaia V, de Oliveira R, Barbosa CP, et al. Prevalence of preeclampsia and eclampsia in adolescent pregnancy: A systematic review and meta-analysis of 291,247 adolescents worldwide since 1969. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2020;248:177-86.
2. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970-5.
3. Qiu D, Wu J, Li M, Wang L, Zhu X, Chen Y. Impaction of factors associated with oxidative stress on the pathogenesis of gestational hypertension and preeclampsia: A Chinese patients based study. Medicine. 2021;100(11).
4. Kweider N, Wruck C, Rath W. New insights into the pathogenesis of preeclampsia–the role of nrf2 activators and their potential therapeutic impact. Geburtshilfe und Frauenheilkunde. 2013;73(12):1236.
5. Yu L, Kuang L-Y, He F, Du L-L, Li Q-L, Sun W, et al. The role and molecular mechanism of long nocoding RNA-MEG3 in the pathogenesis of Preeclampsia. Reproductive Sciences. 2018;25(12):1619-28.
6. Feng H, Wang L, Zhang G, Zhang Z, Guo W. Oxidative stress activated by Keap-1/Nrf2 signaling pathway in pathogenesis of preeclampsia. International journal of clinical and experimental pathology. 2020;13(3):382.
7. Stepan H, Heihoff‐Klose A, Faber R. Reduced antioxidant capacity in second‐trimester pregnancies with pathological uterine perfusion. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2004;23(6):579-83.
8. Dhamodharan U, Ponjayanthi B, Sireesh D, Bhakkiyalakshmi E, Ramkumar KM. Association of single-nucleotide polymorphisms of the KEAP1 gene with the risk of various human diseases and its functional impact using in silico analysis. Pharmacological research. 2018;137:205-18.
9. Zhang Y, Zou Y, Wang W, Zuo Q, Jiang Z, Sun M, et al. Down‐regulated long non‐coding RNA MEG3 and its effect on promoting apoptosis and suppressing migration of trophoblast cells. Journal of cellular biochemistry. 2015;116(4):542-50.
10. Rezavand N, Tabarok S, Rahimi Z, Vaisi‐Raygani A, Mohammadi E, Rahimi Z. The effect of VDR gene polymorphisms and vitamin D level on blood pressure, risk of preeclampsia, gestational age, and body mass index. Journal of cellular biochemistry. 2019;120(4):6441-8.
11. Rahimi Z, Felehgari V, Rahimi M, Mozafari H, Yari K, Vaisi-Raygani A, Rezaei M, Malek-Khosravi Sh, Khazaie H. The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria. Mol Biol Rep. 2011;38(3):2117-23
12. Kagami M, Sekita Y, Nishimura G, Irie M, Kato F, Okada M, et al. Deletions and epimutations affecting the human 14q32. 2 imprinted region in individuals with paternal and maternal upd (14)-like phenotypes. Nature genetics. 2008;40(2):237-42.
13. Dacaj R, Izetbegovic S, Stojkanovic G, Dreshaj S. Elevated liver enzymes in cases of preeclampsia and intrauterine growth restriction. Medical Archives. 2016;70(1):44.
14. Belirteçleri PM, Riyad SAdYB. Liver Function Tests as Probable Markers of Preeclampsia-A Prospective Study Conducted in Riyadh. J Clin Anal Med 2015;6(4): 461-4
15. Cho GJ, Kim HY, Park JH, Ahn KH, Hong SC, Oh MJ, et al. Prepregnancy liver enzyme levels and risk of preeclampsia in a subsequent pregnancy: A population‐based cohort study. Liver International. 2018;38(5):949-54.
16. Hassanpour S, Karami S. Evaluation of Hepatic Biomarkers in Pregnant Women with Preeclampsia. Gynecol Obstet (Sunnyvale). 2018;8(487):2161-0932.1000487.
17. Varkonyi T, Nagy B, Füle T, Tarca A, Karaszi K, Schönléber J, et al. Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar. Placenta. 2011;32:S21-S9.
18. Kuper SG, Tita AT, Youngstrom ML, Allen SE, Tang Y, Biggio JR, et al. Baseline Renal Function Tests and Adverse Outcomes in Patients With Chronic Hypertension. Obstetrics and gynecology. 2016;128(1):93.
19. Ambad RS, Dhok D. The role of serum urea, creatinine, uric acid in diagnosis of pre-eclampsia and eclampsia. Int J Med Biomed Stud. 2019;3:77-80.
20. Phipps E, Prasanna D, Brima W, Jim B. Preeclampsia: updates in pathogenesis, definitions, and guidelines. Clinical Journal of the American Society of Nephrology. 2016;11(6):1102-13.
21. Siedlinski M, Postma DS, Boer JM, van der Steege G, Schouten JP, Smit HA, et al. Level and course of FEV 1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population. Respiratory research. 2009;10(1):1-12.
22. Hartikainen JM, Tengström M, Winqvist R, Jukkola-Vuorinen A, Pylkäs K, Kosma V-M, et al. KEAP1 genetic polymorphisms associate with breast cancer risk and survival outcomes. Clinical Cancer Research. 2015;21(7):1591-601.
23. Testa A, Leonardis D, Spoto B, Sanguedolce MC, Parlongo RM, Pisano A, et al. A polymorphism in a major antioxidant gene (Kelch-like ECH-associated protein 1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study. Journal of hypertension. 2016;34(5):928-34.
24. Moradi M-T, Rahimi Z, Vaisi-Raygani A. New insight into the role of long non-coding RNAs in the pathogenesis of preeclampsia. Hypertension in pregnancy. 2019;38(1):41-51.
25. Gallardo-Escribano C, Buonaiuto V, Ruiz-Moreno MI, Vargas-Candela A, Vilches-Perez A, Benitez-Porres J, et al. Epigenetic approach in obesity: DNA methylation in a prepubertal population which underwent a lifestyle modification Clinical Epigenetics. 2020; 12:144